Armistice Capital, LLC 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:01 pm Sale |
2024-09-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 0 0.000% |
-5,200,000 (Position Closed) |
Filing |
| 2024-02-14 2:26 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 5,200,000 6.490% |
28,000 (+0.54%) |
Filing |
| 2023-02-14 12:32 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 5,172,000 7.650% |
1,741,846 (+50.78%) |
Filing |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 3,430,154 5.900% |
3,430,154 (New Position) |
Filing |